Разработка научных основ создания технологии выделения и очистки генно-инженерных белков (1090305), страница 43
Текст из файла (страница 43)
P.180-187.F176Grillari J., Fortschegger K., Grabherr R.M., Hohenwarter O., Kunert R., Katinger H. /Analysis of alterations in gene expression after amplification of recombinant genes in CHOcells // J. Biotechnol. 2001. V.87 (1). P.59-65.F291F177Senger R.S., Karim M.N. / Effect of shear stress on intrinsic CHO culture state andglycosylation of recombinant tissue-type plasminogen activator protein // Biotechnol. Prog.2003. V.19(4). P.1199-1209.F178Barnes L.M., Bentley C.M., Dickson A.J.
/ Characterization of the stability ofrecombinant protein production in the GS-NS0 expression system // Biotechnol. Bioeng.2001. V.73 (4). P.261-270.F179Jones D., Kroos N., Anema R., van Montfort B., Vooys A., van der Kraats S., van derHelm E., Smits S., Schouten J., Brouwer K., Lagerwerf F., van Berkel P., Opstelten D.J.,Logtenberg T., Bout A. / High-level expression of recombinant IgG in the human cell lineper.c6 // Biotechnol. Prog. 2003. V.19 (1).P.163-168.F180Bout A. / PER.C6 for Protein Production // Williamsburg Bioprocessing Conference,Amsterdam, The Netherlands. 2004.F181Fussenegger M., Bailey J.E. / Molecular regulation of cell-cycle progression andapoptosis in mammalian cells: implications for biotechnology // Biotechnol.
Prog. 1998. V.14(6).P.807-833.F182Fussenegger M., Bailey J.E., Hauser H., Mueller P.P. / Genetic optimization ofrecombinant glycoprotein production by mammalian cells // Trends Biotechnol. 1999. V.17(1).P.35-42.F183Fux C., Moser S., Schlatter S., Rimann M., Bailey J.E., Fussenegger M. / Streptograminand tetracycline-responsive dual regulated expression of p27(Kip1) sense and antisenseenables positive and negative growth control of Chinese hamster ovary cells // Nucleic AcidsRes. 2001. V.29 (4). P.E19.F184Bi J.X., Shuttleworth J., Al-Rubeai M. / Uncoupling of cell growth and proliferationresults in enhancement of productivity in p21CIP1-arrested CHO cells // Biotechnol.
Bioeng.2004. V.85 (7). P.741-749.F185Simpson N.H., Singh R.P., Emery A.N., Al-Rubeai M. / Bcl-2 over-expression reducesgrowth rate and prolongs G1 phase in continuous chemostat cultures of hybridoma cells //Biotechnol. Bioeng. 1999. V.64 (2). P.174-86.F186Figueroa B. Jr, Sauerwald T.M., Oyler G.A., Hardwick J.M., Betenbaugh M.J. / AComparison of the Properties of a Bcl-xL Variant to the Wild-Type Anti-Apoptosis Inhibitor inMammalian Cell Cultures // Metab. Eng.
2003. V.4. P.230-245.F292F187Simpson N.H., Singh R.P., Perani A., Goldenzon C., Al-Rubeai M. / In hybridomacultures, deprivation of any single amino acid leads to apoptotic death, which is suppressed bythe expression of the bcl-2 gene // Biotechnol. Bioeng. 1998. V.59 (1).P.90-98.F188Ishaque A., Al-Rubeai M. / Role of Ca2+, Mg2+ and K+ ions in determining apoptosisand extent of suppression afforded by bcl-2 during hybridoma cell culture // Apoptosis.
1999.V.4 (5). P.335-355.F189Ishaque A., Al-Rubeai M. / Role of vitamins in determining apoptosis and extent ofsuppression by bcl-2 during hybridoma cell culture // Apoptosis. 2002. V.7 (3). P.231-239.F190Kwaks T.H., Barnett P., Hemrika W., Siersma T., Sewalt R.G., Satijn D.P., Brons J.F., vanBlokland R., Kwakman P., Kruckeberg A.L., Kelder A., Otte A.P. / Identification of AntiRepressor Elements that Confer High and Stable Protein Production in Mammalian Cells //Nat Biotechnol. 2003.
V.21 (5). P.553-558.F191Fukuda Y., Nishikawa S. / Matrix Attachment Regions Enhance Transcription of aDownstream Transgene and the Accessibility of Its Promoter Region to Micrococcal Nuclease// Plant Mol. Biol. 2003. V.51 (5). P.665-675.F192Kwaks T.H., Otte A.P.
/ Employing Epigenetics to Augment the Expression ofTherapeutic Proteins in Mammalian Cells // Trends Biotechnol. 2006. V.24 (3). P.137-142.F193Duncan A., Hadlaczky G. / Chromosomal Engineering // Curr. Opin. Biotechnol. 2007.V.18 (5). P.420-424.F194Reik A., Zhou Y., Collingwood T.N., Warfe L., Bartsevich V., Kong Y., Henning K.A.,Fallentine B.K., Zhang L., Zhong X., Jouvenot Y., Jamieson A.C., Rebar E.J., Case C.C.,Korman A., Li X.Y., Black A., King D.J., Gregory P.D.
/ Enhanced Protein Production ByEngineered Zinc Finger Proteins // Biotechnol. Bioeng. 2007. V.97 (5). P.1180-1189.F195Baker K.N., Rendall M.H., Hills A.E., Hoare M., Freedman R.B., James D.C. / MetabolicControl of Recombinant Protein N-Glycan Processing in NS0 and CHO Cells // Biotechnol.Bioeng. 2001. V.73 (3).
P.188-202.F196Zhang F., Saarinen M.A., Itle L.J., Lang S.C., Murhammer D.W., Linhardt R.J. / TheEffect of Dissolved Oxygen (DO) Concentration on the Glycosylation of Recombinant ProteinProduced By the Insect Cell-Baculovirus Expression System // Biotechnol. Bioeng. 2002. V.77 (2). P.219-224.F293F197Imperiali B., Rickert K.W. / Conformational implications of asparagine-linkedglycosylation // Proc. Natl. Acad. Sci. USA.
1995. V.92. P.97-101.F198Ware F.E., Vassilakos A., Peterson P.A., Jackson M.R., Lehrman M.A., Williams D.B. /The molecular chaperone calnexin binds Glc1Man9GlcNAc2 oligosaccharide as an initial stepin recognizing unfolded glycoproteins // J. Biol. Chem. 1995. V.270. P.4697-704.F199Devasahayam M. / Factors affecting the expression of recombinant glycoproteins //Indian J.
Med. Res. 2007. V.126. P.22-27.F200Hebert D.N., Garman S.C., Molinari M. / The glycan code of the endoplasmic reticulum:asparagine-linked carbohydrates as protein maturation and quality-control tags // Trends Cell.Biol. 2005. V.15. P.364-370.F201Werner R.G., Noe W., Kopp K., Schluter M. / Appropriate mammalian expressionsystems for biopharmaceuticals. // Arzneimittelforschun.
1998. V.48. P.870-880.F202Anderson K.S., Cresswell P. / A role for calnexin (IP90) in the assembly of class II MHCmolecules // EMBO J. 1994. V.13. P.675-682.F203Hammond C., Braakman I., Helenius A. / Role of N-linked oligosaccharide recognition,glucose trimming, and calnexin in glycoprotein folding and quality control // Proc. Natl. Acad.Sci. USA. 1994. V.91. P.913-917.F204Gavel Y., von Heijne G. / Sequence differences between glycosylated and nonglycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering // ProteinEng. 1990. V.3.
P.433-442.F205Shakin-Eshleman S.H., Spitalnik S.L., Kasturi L. / The amino acid at the X position of anAsn-X-Ser sequon is an important determinant of N-linked core-glycosylation efficiency // J.Biol. Chem. 1996. V.271. P.6363-6366.F206Imperiali B., Shannon K.L. / Differences between Asn-Xaa-Thrcontaining peptides: acomparison of solution conformation and substrate behavior with oligosaccharyltransferase //Biochemistry. 1991. V.30.
P.4374-4380.F207Davidson D.J., Castellino F.J. / Structures of the asparagine-289-linked oligosaccharidesassembled on recombinant human plasminogen expressed in a Mamestra brassicae cell line(IZDMBO503) // Biochemistry. 1991. V.30. P.6689-6696.F208Gramer M.J., Goochee C.F. / Glycosidase activities in Chinese hamster ovary cell lysateand cell culture supernatant // Biotechnol. Prog. 1993.
V.9. P.366-373.F294F209Prence E.M., Natowicz M.R. / Diagnosis of alpha-mannosidosis by measuring alphamannosidase in plasma // Clin. Chem. 1992. V.38. P.501-503.F210Gramer M.J., Schaffer D.V., Sliwkowski M.B., Goochee C.F. / Purification andcharacterization of alpha-L-fucosidase from Chinese hamster ovary cell lysate and cell culturesupernatant // Biotechnol. Prog.
1993. V.9. P.366-373.F211Le Floch F., Tessier B., Chenuet S., Guillaume J.M., Cans P., Marc A. / HPCE monitoringof the N-glycosylation pattern and sialylation of murine erythropoietin produced by CHOcells in batch processes // Biotechnol. Prog. 2004. V.20. P.864-871.F212Takeuchi M., Inoue N., Strickland T.W., Kubota M., Wada M., Shimizu R. / Relationshipbetween sugar chain structureand biological activity of recombinant human erythropoietin produced in Chinese hamsterovary cells // Proc. Natl. Acad. Sci.
USA. 1989. V.86. P.7819-7822.F213Kagawa Y., Takasaki S., Utsumi J., Hosoi K., Shimizu H., Kochibe N. / Comparativestudy of the asparagine-linked sugar chains of natural human interferon-beta 1 andrecombinant human interferon-beta 1 produced by three different mammalian cells // J. Biol.Chem. 1988. V.263.
P.17508-17515.F214Takeuchi M., Takasaki S., Miyazaki H., Kato T., Hoshi S., Kochibe N. / Comparativestudy of the asparagine-linked sugar chains of human erythropoietins purified from urine andthe culture medium of recombinant Chinese hamster ovary cells // J. Biol.
Chem. 1988. V.263.P.3657-3663.F215Galili U., Basbaum C.B., Shohet S.B., Buehler J., Macher B.A. / Identification oferythrocyte Gal alpha 1-3Gal glycosphingolipids with a mouse monoclonal antibody, Gal-13 //J. Biol. Chem. 1987. V.262. P.4683-4688.F216Jayapal K.P., Wlaschin K.F., Hu W.-S., Yap M.G.S. / Recombinant protein therapeuticsfrom CHO-cells – 20 years and counting // CHO Consortium, SBE Special Edition.F217Wiebe M.E. / A multifaceted approach to assure that recombinant tPA is free ofadventitious virus // Advances in animal cell biology and technology, Butterword-Heinemann,London, UK. 1989.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
